Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |